Suppr超能文献

抗有丝分裂剂秋水仙碱对硫代乙酰胺肝毒性的影响。

Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity.

作者信息

Mangipudy R S, Rao P S, Mehendale H M

机构信息

Division of Pharmacology and Toxicology, College of Pharmacy and Health Sciences, Northeast Louisiana University, Monroe 71209-0470, USA.

出版信息

Environ Health Perspect. 1996 Jul;104(7):744-9. doi: 10.1289/ehp.96104744.

Abstract

In an earlier study we established that timely and adequate tissue repair response following the administration of a six-fold dose-range of thioacetamide (TA; 50, 150, and 300 mg/kg) prevented progression of injury and led to recovery and animal survival. Delayed and attenuated repair response after the 600 mg/kg TA dose resulted in a marked progression of injury and 100% lethality. The objective of the present study was to further scrutinize this concept in an experimental protocol in which we hypothesized that a selective ablation of the tissue repair response should lead to lethality from the nonlethal, moderately toxic doses of 150 and 300 mg/kg TA. In this study we investigated the effect of the antimitotic agent colchicine (CLC, 1 mg/kg) on the outcome of TA hepatotoxicity. Male Sprague-Dawley rats (175-225 g) were injected intraperitoneally (ip) with 150 and 300 mg/kg TA. We assessed liver injury by serum enzyme elevations and histopathology. Tissue regeneration response was measured by 3H-thymidine incorporation into hepatonuclear DNA and by proliferating cell nuclear antigen (PCNA) assay. S-Phase stimulation, as indicated by 3H-thymidine incorporation, was noted at 36 and 48 hr following the administration of 150 mg/kg TA, whereas with the 300 mg/kg TA S-phase stimulation was elicited at 48 hr following treatment. Therefore, two doses of CLC (30 hr and 42 hr, 1 mg/kg, ip) were administered to the 150 mg/kg treated group while a single dose of CLC (42 hr, 1 mg/kg, ip) was administered to the 300 mg/kg group. CLC treatment resulted in 100% lethality in both groups. Thus, CLC administration converted nonlethal doses into lethal doses. The 150 mg/kg TA dose was then chosen to further investigate the underlying mechanism. Rats treated with TA alone recovered from injury by 36-48 hr while CLC treatment resulted in a progression of injury as indicated by serum enzyme elevation and histopathology. Tissue repair, as evidenced by 3H-thymidine incorporation and PCNA studies explained this dichotomy. Antimitotic intervention with CLC resulted in a significantly diminished repair response leading to unrestrained progression of injury and lethality even from nonlethal doses. This model demonstrates the critical role of tissue repair response in determining the final outcome of toxicity.

摘要

在一项早期研究中,我们确定,给予硫代乙酰胺(TA;50、150和300 mg/kg)六倍剂量范围后,及时且充分的组织修复反应可防止损伤进展,并导致恢复和动物存活。600 mg/kg TA剂量后延迟且减弱的修复反应导致损伤显著进展和100%致死率。本研究的目的是在一个实验方案中进一步审视这一概念,在该方案中我们假设,选择性消除组织修复反应应导致150和300 mg/kg TA非致死、中度毒性剂量致死。在本研究中,我们研究了抗有丝分裂剂秋水仙碱(CLC,1 mg/kg)对TA肝毒性结果的影响。雄性Sprague-Dawley大鼠(175 - 225 g)腹腔注射(ip)150和300 mg/kg TA。我们通过血清酶升高和组织病理学评估肝损伤。通过将3H-胸腺嘧啶核苷掺入肝细胞核DNA和增殖细胞核抗原(PCNA)测定来测量组织再生反应。给予150 mg/kg TA后36和48小时观察到3H-胸腺嘧啶核苷掺入所表明的S期刺激,而给予300 mg/kg TA后,治疗后48小时引发S期刺激。因此,对150 mg/kg治疗组给予两剂CLC(30小时和42小时,1 mg/kg,ip),而对300 mg/kg组给予一剂CLC(42小时,1 mg/kg,ip)。CLC治疗导致两组100%致死率。因此,给予CLC将非致死剂量转化为致死剂量。然后选择150 mg/kg TA剂量进一步研究潜在机制。单独用TA治疗的大鼠在36 - 48小时从损伤中恢复,而CLC治疗导致损伤进展,如血清酶升高和组织病理学所示。3H-胸腺嘧啶核苷掺入和PCNA研究证明的组织修复解释了这种二分法。用CLC进行抗有丝分裂干预导致修复反应显著减弱,导致即使是非致死剂量的损伤和致死率也不受控制地进展。该模型证明了组织修复反应在确定毒性最终结果中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/661c/1469416/6367bcd73976/envhper00338-0073-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验